Quantum量子訊息有限公司

Therapeutic mRNA Downstream Processing Consumables Market

完整報告名稱與涵蓋範圍
Therapeutic mRNA Downstream Processing Consumables Market Size, Share & Trends Analysis Report, By Consumable Type (Chromatography Resins and Monoliths (Oligo-dT, Ion Exchange, Hydrophobic Interaction), Tangential Flow Filtration Membranes and Cassettes, Sterile and Depth Filters, Single-Use Bags, Tubing and Flow Paths), By Process Step (Capture and Template Removal, Double-Stranded RNA and Impurity Polishing, Concentration, Buffer Exchange and Sterile Filtration), By Scale (Clinical Scale, Commercial Scale), By End User, By Region, and Segment Forecasts, 2026-2035

報告摘要

The therapeutic mRNA downstream processing consumables market covers chromatography resins and monoliths, tangential flow filtration membranes, sterile and depth filters and single-use bags and flow paths used to purify and concentrate messenger RNA drug substance after in vitro transcription. Upstream reagents, lipid nanoparticle formulation consumables and reusable equipment are excluded. Purification determines whether mRNA meets purity and immunogenicity requirements, since double-stranded RNA, residual template, enzymes and truncated transcripts must be removed without degrading long, fragile molecules. Oligo-dT affinity capture, cellulose-based and ion exchange polishing, hydrophobic interaction chromatography and reverse-phase methods each address specific impurities, and monolith and membrane formats suit the large, viscous molecules better than conventional beads. Consumable demand scales with drug substance output and with the number of purification steps, and suppliers are launching mRNA-specific resins with higher capacity, single-use pre-packed columns and filtration cassettes validated for RNA, while manufacturers standardise platform processes that reduce development time. North America and Europe dominate consumption, with Asia Pacific growing as RNA manufacturing capacity expands in China, South Korea, Japan and Singapore. Competition involves bioprocess leaders, chromatography and monolith specialists and filtration and single-use component suppliers. The InsightAce study provides US$ revenue forecasts for every consumable type, process step, scale and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.

授權報價

Single User$4,500 USD
Enterprise / Global Site Licence$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Therapeutic mRNA Downstream Processing Consumables Market Snapshot Chapter 4. Global Therapeutic mRNA Downstream Processing Consumables Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Market Drivers 4.3. Market Challenges 4.4. Emerging Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis - Porter's Five Forces Analysis 4.7. Competitive Landscape and Market Positioning 4.8. Market Opportunity Analysis Chapter 5. Market Segmentation 1: By Consumable Type Estimates & Trend Analysis 5.1. Consumable Type & Market Share, 2026 & 2035 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Consumable Type: 5.2.1. Chromatography Resins and Monoliths (Oligo-dT, Ion Exchange, Hydrophobic Interaction) 5.2.2. Tangential Flow Filtration Membranes and Cassettes 5.2.3. Sterile and Depth Filters 5.2.4. Single-Use Bags, Tubing and Flow Paths Chapter 6. Market Segmentation 2: By Process Step Estimates & Trend Analysis 6.1. Process Step & Market Share, 2026 & 2035 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Process Step: 6.2.1. Capture and Template Removal 6.2.2. Double-Stranded RNA and Impurity Polishing 6.2.3. Concentration, Buffer Exchange and Sterile Filtration Chapter 7. Market Segmentation 3: By Scale Estimates & Trend Analysis 7.1. Scale & Market Share, 2026 & 2035 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Scale: 7.2.1. Clinical Scale 7.2.2. Commercial Scale Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis 8.1. End User & Market Share, 2026 & 2035 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User: 8.2.1. mRNA Manufacturers 8.2.2. CDMOs 8.2.3. Academic and Research Institutes Chapter 9. Therapeutic mRNA Downstream Processing Consumables Market: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. United States 9.1.2. Canada 9.2. Europe 9.2.1. Germany 9.2.2. United Kingdom 9.2.3. France 9.2.4. Italy 9.2.5. Spain 9.2.6. Rest of Europe 9.3. Asia Pacific 9.3.1. China 9.3.2. Japan 9.3.3. India 9.3.4. South Korea 9.3.5. Australia 9.3.6. Southeast Asia 9.3.7. Rest of Asia Pacific 9.4. Latin America 9.4.1. Brazil 9.4.2. Mexico 9.4.3. Rest of Latin America 9.5. Middle East & Africa 9.5.1. GCC Countries 9.5.2. South Africa 9.5.3. Rest of Middle East & Africa Chapter 10. Competitive Landscape 10.1. Company Market Positioning Analysis 10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A) Chapter 11. Company Profiles 11.1. Thermo Fisher Scientific Inc. 11.2. Sartorius BIA Separations 11.3. Cytiva (Danaher) 11.4. Merck KGaA (MilliporeSigma) 11.5. Repligen Corporation 11.6. Tosoh Bioscience 11.7. Bio-Rad Laboratories, Inc. 11.8. Pall Corporation (Danaher) 11.9. Purolite (Ecolab) 11.10. Asahi Kasei Bioprocess 11.11. Avantor, Inc. 11.12. 3M Company (Solventum Separation Technologies) 11.13. Astrea Bioseparations 11.14. JSR Life Sciences (Amsphere) 11.15. Bio-Works Technologies AB

圖表清單 List of Tables & Figures

Table 1. Global Therapeutic mRNA Downstream Processing Consumables Market Revenue Forecast by Consumable Type, 2026-2035 (US$ Mn) Figure 1. Global Therapeutic mRNA Downstream Processing Consumables Market Segmentation Overview Table 2. Global Therapeutic mRNA Downstream Processing Consumables Market Revenue Forecast by Process Step, 2026-2035 (US$ Mn) Figure 2. Global Therapeutic mRNA Downstream Processing Consumables Market Share by Consumable Type, 2026 & 2035 Table 3. Global Therapeutic mRNA Downstream Processing Consumables Market Revenue Forecast by Scale, 2026-2035 (US$ Mn) Figure 3. mRNA Purification Train and Impurity Removal by Unit Operation Table 4. Global Therapeutic mRNA Downstream Processing Consumables Market Revenue Forecast by End User, 2026-2035 (US$ Mn) Figure 4. Global Therapeutic mRNA Downstream Processing Consumables Market Share by Process Step, 2026 & 2035 Table 5. North America Therapeutic mRNA Downstream Processing Consumables Market Revenue by Country, 2026-2035 (US$ Mn) Figure 5. mRNA-Specific Resin and Monolith Product Introductions, 2022-2026 Table 6. Europe Therapeutic mRNA Downstream Processing Consumables Market Revenue by Country, 2026-2035 (US$ Mn) Figure 6. Asia Pacific Therapeutic mRNA Downstream Processing Consumables Growth Opportunity Analysis Table 7. Asia Pacific Therapeutic mRNA Downstream Processing Consumables Market Revenue by Country, 2026-2035 (US$ Mn) Figure 7. Consumable Cost per Gram of mRNA Drug Substance Across Process Designs Table 8. Latin America Therapeutic mRNA Downstream Processing Consumables Market Revenue by Country, 2026-2035 (US$ Mn) Figure 8. Competitive Positioning of Key Therapeutic mRNA Downstream Processing Consumables Market Participants Table 9. Middle East & Africa Therapeutic mRNA Downstream Processing Consumables Market Revenue by Country, 2026-2035 (US$ Mn)

提及公司

Thermo Fisher Scientific Inc.Sartorius BIA SeparationsCytiva (Danaher)Merck KGaA (MilliporeSigma)Repligen CorporationTosoh BioscienceBio-Rad Laboratories, Inc.Pall Corporation (Danaher)Purolite (Ecolab)Asahi Kasei BioprocessAvantor, Inc.3M Company (Solventum Separation Technologies)Astrea BioseparationsJSR Life Sciences (Amsphere)Bio-Works Technologies AB

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們